Imperial College London

Professor Mark Layton

Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Practice (Haematology)
 
 
 
//

Contact

 

+44 (0)20 3313 2173m.layton

 
 
//

Assistant

 

Mrs Lisa Pape +44 (0)20 3313 1320

 
//

Location

 

4N3ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Kuo:2021:10.1182/blood-2021-150386,
author = {Kuo, KHM and Layton, DM and Lal, A and Al-Samkari, H and Bhatia, J and Kosinski, PA and Tong, B and Lynch, M and Uhlig, K and Vichinsky, E},
doi = {10.1182/blood-2021-150386},
publisher = {AMER SOC HEMATOLOGY},
title = {Long-Term Efficacy and Safety of the Oral Pyruvate Kinase Activator Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia},
url = {http://dx.doi.org/10.1182/blood-2021-150386},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Kuo,KHM
AU - Layton,DM
AU - Lal,A
AU - Al-Samkari,H
AU - Bhatia,J
AU - Kosinski,PA
AU - Tong,B
AU - Lynch,M
AU - Uhlig,K
AU - Vichinsky,E
DO - 10.1182/blood-2021-150386
PB - AMER SOC HEMATOLOGY
PY - 2021///
SN - 0006-4971
TI - Long-Term Efficacy and Safety of the Oral Pyruvate Kinase Activator Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
UR - http://dx.doi.org/10.1182/blood-2021-150386
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000736398802117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -